SK Bioscience Conducts L-House Training for WHO Workforce Development Hub Trainees

Trainees from the World Health Organization (WHO) Workforce Development Hub are touring SK Bioscience L House in Andong-si, Gyeongbuk, and taking a commemorative photo. (Photo by SK Bioscience)

[Asia Economy Reporter Chunhee Lee] SK Bioscience announced on the 3rd that it conducted vaccine production process training for trainees at the World Health Organization (WHO) workforce training hub at L House in Andong-si, Gyeongbuk.

This training program, jointly promoted by the Ministry of Health and Welfare, the Ministry of Economy and Finance, Yonsei University K-NIBRT Project Group, and the Asian Development Bank (ADB), was carried out to bridge regional gaps in vaccine production capabilities by nurturing vaccine production talent from middle- and low-income countries, following WHO's sole designation of South Korea as a global bio workforce training hub in February.

During the training, 26 trainees from 12 developing countries within the ADB region, including Vietnam, Indonesia, and Thailand, had the opportunity to directly observe the production facilities of the first domestically developed COVID-19 vaccine, 'Skycovione Multi.' The trainees toured L House, experiencing the vaccine production process firsthand by visiting the vaccine bulk and finished product production facilities, as well as the quality control testing laboratories.

L House is the first domestic vaccine manufacturing facility to obtain EU-GMP (Good Manufacturing Practice) certification approved by the European Medicines Agency (EMA). In addition, it has acquired GMP certifications from WHO, the United Kingdom, Russia, and Turkey.

Mozahidur Rahaman from Bangladesh said, "It was a valuable time to see and feel with my own eyes a global-level production facility where various types of vaccines, which I had only experienced theoretically, are produced," adding, "I was inspired to grow so that I can protect more people’s safety in the future when new viruses emerge."

Jae-yong Ahn, President of SK Bioscience, stated, "Global bio workforce development is the responsibility of stakeholders in the vaccine field and the most fundamental effort to protect humanity from new pandemics," and added, "Starting with this training, we will support the growth of bio talents both domestically and internationally in every possible way."

This content was produced with the assistance of AI translation services.